Cytosorbents (CTSO) Research & Development (2016 - 2024)
Historic Research & Development for Cytosorbents (CTSO) over the last 14 years, with Q3 2024 value amounting to $1.9 million.
- Cytosorbents' Research & Development fell 5062.33% to $1.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $9.7 million, marking a year-over-year decrease of 3537.77%. This contributed to the annual value of $15.7 million for FY2023, which is 403.47% up from last year.
- Per Cytosorbents' latest filing, its Research & Development stood at $1.9 million for Q3 2024, which was down 5062.33% from $1.5 million recorded in Q2 2024.
- Cytosorbents' Research & Development's 5-year high stood at $6.1 million during Q4 2021, with a 5-year trough of $1.5 million in Q2 2024.
- Over the past 5 years, Cytosorbents' median Research & Development value was $3.4 million (recorded in 2022), while the average stood at $3.2 million.
- Per our database at Business Quant, Cytosorbents' Research & Development skyrocketed by 14307.47% in 2021 and then plummeted by 5858.0% in 2024.
- Cytosorbents' Research & Development (Quarter) stood at $2.7 million in 2020, then surged by 128.51% to $6.1 million in 2021, then plummeted by 44.57% to $3.4 million in 2022, then increased by 20.42% to $4.1 million in 2023, then plummeted by 54.81% to $1.9 million in 2024.
- Its last three reported values are $1.9 million in Q3 2024, $1.5 million for Q2 2024, and $2.2 million during Q1 2024.